Related Experiment Video

Updated: Aug 21, 2026

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis

Beatrice De Vos1, Timo Vesikari, Alexandre C Linhares

  • 1GlaxoSmithKline Biologicals, Rixensart, Belgium.

The Pediatric Infectious Disease Journal
|October 27, 2004
PubMed

Insights

A new rotavirus vaccine, Rotarix, is safe and effective in infants. It significantly reduced rotavirus gastroenteritis and hospitalizations, showing promise for global disease reduction.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Infectious Diseases

Background:

  • Rotavirus gastroenteritis poses a significant health burden in children globally.
  • Development of safe and effective rotavirus vaccines is crucial for reducing childhood morbidity and mortality.

Purpose of the Study:

  • To evaluate the safety, immunogenicity, and efficacy of a live attenuated monovalent rotavirus vaccine (Rotarix, strain RIX4414) in infants.
  • To assess vaccine performance in diverse geographical and healthcare settings.

Main Methods:

  • Overview of three clinical trials involving 5024 infants in Finland, Latin America, and Singapore.
  • Assessment of solicited symptoms, rotavirus-specific IgA antibody response, and interference with routine pediatric vaccines.
  • Evaluation of vaccine efficacy against rotavirus gastroenteritis and hospitalizations.

Main Results:

  • Rotarix was well-tolerated with no increase in solicited symptoms compared to placebo.
  • 61-91% of infants developed rotavirus-specific IgA antibodies after two doses.
  • Significant reduction in rotavirus gastroenteritis episodes and hospitalizations (P < 0.05).
  • Efficacy observed against G1 and non-G1 rotavirus strains, including G9, in Latin America (P < 0.05).

Conclusions:

  • Rotarix demonstrates a favorable safety and immunogenicity profile in infants.
  • The vaccine significantly reduces the burden of rotavirus gastroenteritis and related hospitalizations.
  • Rotarix shows potential for widespread use in reducing global rotavirus disease.

More Related Videos

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Vaccinations01:51

Vaccinations

Overview
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...